Expected results from clinical study

Eurocine Vaccines expect to present the results from the ongoing PhaseI/II study with the the first product candidate Immunose™ FLU.

Do you want to follow Eurocine Vaccines development?

Share our ambition developing more effective vaccines. Fill in your e-mail address and we will update you with the latest Press Releases and Stories.

Start your subscription here »